Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Moxaverine Effects on Ocular Blood Flow in Healthy Subjects
NCT01629680Phase 2Completed
- Sponsor
- Medical University of Vienna
- Start
- Oct 2010
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of moxaverine in age-related macular degeneration (AMD), Glaucoma, sponsored by Medical University of Vienna. Started Oct 2010; status: completed.
02
Drugs
moxaverine
03
Conditions
age-related macular degeneration (AMD)Glaucoma
Beyond the preview
Go deeper on NCT01629680.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01629680.